Gender Oncology: Rethinking Cancer Through a Sex- and Gender-Based Lens
Journal of Clinical Medicine · 11.07.2026 · 15 (14) · 5435
DOI: 10.3390/jcm15145435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.07.2026. Verfasst von Rossana Berardi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Università Politecnica delle Marche, AOU Marche, 60126 Ancona, Italy. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Gender medicine is an emerging approach that recognizes how biological sex, gender identity, and sociocultural roles influence health and disease. These factors can significantly affect prevention, screening, diagnosis, and treatment outcomes. In oncology, accumulating evidence highlights sex-based differences in cancer incidence, therapeutic response, and treatment-related adverse events. A comprehensive gender-based approach should also address the specific needs of sexual and gender minority (SGM) populations. Based on the existing literature and the authors’ expertise, this perspective paper provides an overview of this topic, emphasizing its importance, discussing current challenges, and proposing potential future directions for research and clinical practice. The literature discussed in this article was selected through a narrative, rather than a systematic, approach and is intended to provide the scientific context supporting the authors’ perspective and interpretation of the current evidence.
Methods
To investigate gender differences in oncology regarding epidemiological data, we queried the AIRTUM and GLOBOCAN databases. Furthermore, we conducted a bibliography search of scientific papers by querying PubMed/MEDLINE to explore gender differences, in particular regarding treatments. The database was searched by looking for papers published between 1 January 2022 and 31 December 2025.
Results
Cancers affecting both sexes show higher incidence and mortality rates in men, a trend observed worldwide and confirmed by national data. However, important sex-related differences also emerge in treatment response. Women appear to derive a smaller survival benefit than men from immunotherapy alone but may experience greater benefit when immunotherapy is combined with chemotherapy. These differences may be explained by distinct molecular mechanisms underlying antitumor immune responses in males and females. Furthermore, women experience higher rates of treatment-related toxicities, likely due to sex-specific differences in pharmacokinetics and pharmacodynamics.
Conclusions
Integrating sex and gender perspectives into oncology is essential for advancing personalized medicine and improving patient care. Understanding biological differences can help optimize treatment selection and dosing strategies, thereby enhancing efficacy while minimizing adverse effects. At the same time, addressing gender-related factors may improve psychosocial support, patient well-being, and treatment adherence. Achieving these goals requires coordinated efforts, including sex-disaggregated research, gender-sensitive clinical protocols, and healthcare policies aimed at reducing gender disparities in cancer care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Università Politecnica delle Marche, AOU Marche, 60126 Ancona, Italy.
ORCID-Profile: Rossana Berardi, Carolina Liguori
Zitieren
APA
Berardi, R., Liguori, C., & Rossi, F. (2026). Gender Oncology: Rethinking Cancer Through a Sex- and Gender-Based Lens. Journal of Clinical Medicine, 15(14), 5435. https://doi.org/10.3390/jcm15145435
Vancouver
Berardi R, Liguori C, Rossi F. Gender Oncology: Rethinking Cancer Through a Sex- and Gender-Based Lens. Journal of Clinical Medicine. 2026;15(14):5435. doi:10.3390/jcm15145435
BibTeX
@article{Berardi2026,
author = {Berardi, Rossana and Liguori, Carolina and Rossi, Francesca},
title = {Gender Oncology: Rethinking Cancer Through a Sex- and Gender-Based Lens},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {14},
pages = {5435},
doi = {10.3390/jcm15145435}
}
EUVIMED